QUCY Mainz Biomed N.V. - Ordinary Shares
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026
$1.33
· of 52w range
· above low
· to high
$0.3052w low
$4.9352w high
Market Cap (MRQ)
$13M
EPS
$-2.70
Revenue
$537.1K
your badges
52W Range
$0–$5
Analyst Rating
BUY
Price Target
$9
P/E
·
ROE
-488.3%
Net Profit Margin
-3018.3%
Your badge strip is empty — pin a metric anywhere on this page.
QUCY Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.33
Market Cap (MRQ)
$13M
EPS
$-2.70
Revenue
$537.1K
ROE
-488.3%
Debt/Equity
1.5
52W Range
$0–$5
QUCY Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$537.1K2024-12-31 → 2025-12-31
EPS$-2.702024-12-31 → 2025-12-31
Free Cash Flow$-11M2025-12-31 → 2025-12-31
Net margin-3018.3%2025-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | QUCY | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 0.6 | · | · | · | |
| Price / Tangible Book (MRQ) | 0.9 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | QUCY | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 72.6% | · | · | · | |
| Operating Margin | -3005.0% | · | · | · | |
| EBITDA Margin | -2890.3% | · | · | · | |
| Pretax Margin | -3018.3% | · | · | · | |
| Net Profit Margin | -3018.3% | · | · | · | |
| ROA | -172.2% | · | · | · | |
| ROE | -488.3% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | QUCY | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity | 1.5 | · | · | · | |
| Current Ratio (MRQ) | 5.6 | · | · | · | |
| Quick Ratio | 0.2 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | QUCY | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -39.9% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | QUCY | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | · | |
| Inventory Turnover | 0.5 | · | · | · | |
| Revenue / Employee | ≈$53.7K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
2.9%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 14, 2026 | $-0.62 | $-0.64 | 3.5% |
| Dec. 31, 2023 | $-9.60 | $-12.92 | 25.7% | |
| Sept. 30, 2023 | $-15.60 | $-19.31 | 19.2% | |
| June 30, 2023 | $-22.40 | $-17.14 | -30.7% | |
| March 31, 2023 | $-0.45 | $-0.44 | -3.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $537.1K | $894.0K | |
| Cost of Revenue | $147.3K | $319.1K | |
| Gross Profit | $389.8K | $574.9K | |
| R&D Expense | $5M | $6M | |
| SG&A Expense | $5M | $7M | |
| Operating Expenses | $17M | $19M | |
| Operating Income | $-16M | $-19M | |
| Other Non-op | $-71.6K | $-3M | |
| Pretax Income | $-16M | $-22M | |
| Net Income | $-16M | $-22M | |
| EPS (Basic) | $-2.70 | $-21.91 | |
| EPS (Diluted) | $-2.70 | $-21.91 | |
| Shares (Basic) | 5,996,887 | 985,717 | |
| Shares (Diluted) | 5,996,887 | 985,717 | |
| EBITDA | $-16M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $889.1K | $6M | |
| Inventory | $216.9K | $372.9K | |
| Prepaid Expense | $466.7K | $1M | |
| Current Assets | $4M | $8M | |
| PP&E (Net) | · | $1M | |
| PP&E (Gross) | $2M | $2M | |
| Accum. Depreciation | $655.3K | $462.5K | |
| Intangibles | $1M | $3M | |
| Total Assets | $5M | $14M | |
| Accounts Payable | $60.7K | $1M | |
| Accrued Liabilities | $55.8K | $302.6K | |
| Short-term Debt | $956.9K | $1M | |
| Current Liabilities | $5M | $6M | |
| Capital Leases | $992.5K | $945.2K | |
| Total Liabilities | $5M | $8M | |
| Total Debt | $956.9K | · | |
| Common Stock | $107.8K | $23.1K | |
| Paid-in Capital | $106M | · | |
| Retained Earnings | $-105M | $-89M | |
| AOCI | $-617.7K | $-548.6K | |
| Stockholders' Equity | $641.6K | $6M | |
| Liabilities + Equity | $5M | $14M | |
| Shares Outstanding | 9,780,142 | 2,319,353 |
Cash Flow
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $615.7K | $696.6K | |
| Stock-based Comp | $1M | $-63.1K | |
| Amort. of Intangibles | $377.2K | $377.2K | |
| Other Non-cash | $3M | · | |
| Operating Cash Flow | $-11M | $-17M | |
| CapEx | $1.2K | $104.9K | |
| Investing Cash Flow | $-1M | $-198.8K | |
| Financing Cash Flow | $7M | $17M | |
| Net Change in Cash | $-5M | $-835.3K | |
| Taxes Paid | $178.6K | $150.0K | |
| Free Cash Flow | $-11M | · |
Profitability
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Gross Margin | 72.6% | · | |
| Operating Margin | -3005.0% | · | |
| Net Margin | -3018.3% | · | |
| Pretax Margin | -3018.3% | · | |
| EBITDA Margin | -2890.3% | · | |
| ROA | -172.2% | · | |
| ROE | -488.3% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 0.5 | · | |
| Quick Ratio | 0.2 | · | |
| Debt / Equity | 1.5 | · |
Efficiency
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.1 | · | |
| Inventory Turnover | 0.5 | · |
Per Share
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Book Value / Share | $0.07 | · | |
| Revenue / Share | $0.09 | · | |
| Cash Flow / Share | $-1.83 | · | |
| Cash / Share | $0.09 | · | |
| EPS (TTM) | $-2.70 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | -39.9% | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $537.1K | · | |
| Net Income TTM | $-16M | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| R&D Expense | $5M | $59.3K | · | $101.3K | $88.7K | |
| SG&A Expense | $4M | $2M | · | $671.0K | $1M | |
| Operating Expenses | $10M | $2M | · | $2M | $3M | |
| Operating Income | $-10M | $-2M | · | $-2M | $-3M | |
| Other Non-op | $-183.4K | $-22.6K | · | $-51.9K | $-21.9K | |
| Pretax Income | $-10M | $-2M | · | $-2M | $-3M | |
| Net Income | $-11M | $-5M | · | $-3M | $-5M | |
| EPS (Basic) | $-0.62 | $-0.43 | · | $-0.80 | $-1.46 | |
| EPS (Diluted) | $-0.62 | $-0.43 | · | $-0.80 | $-1.46 | |
| Shares (Basic) | 17,851,499 | 11,799,424 | · | 4,369,699 | 3,430,902 | |
| Shares (Diluted) | 17,851,499 | 11,799,424 | · | 4,369,699 | 3,430,902 | |
| EBITDA | $-10M | $-2M | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $5M | $889.1K | · | · | |
| Inventory | · | · | $216.9K | · | · | |
| Prepaid Expense | $3M | $265.9K | $657.3K | · | · | |
| Current Assets | $17M | $7M | $2M | · | · | |
| PP&E (Net) | $136.8K | · | $1M | · | · | |
| PP&E (Gross) | · | · | $2M | · | · | |
| Accum. Depreciation | · | · | $655.3K | · | · | |
| Intangibles | $7M | $1M | $1M | · | · | |
| Total Assets | $23M | $8M | $5M | · | · | |
| Accounts Payable | $807.8K | $150.2K | $411.1K | · | · | |
| Accrued Liabilities | $93.1K | $19.7K | $99.3K | · | · | |
| Short-term Debt | · | · | $956.9K | · | · | |
| Current Liabilities | $3M | $3M | $4M | · | · | |
| Capital Leases | · | · | $992.5K | · | · | |
| Total Liabilities | $3M | $3M | $5M | · | · | |
| Common Stock | $286.1K | $140.0K | $107.8K | · | · | |
| Paid-in Capital | $141M | $115M | · | · | · | |
| Retained Earnings | $-121M | $-110M | $-105M | · | · | |
| AOCI | · | $-652.8K | $-617.7K | · | · | |
| Stockholders' Equity | $20M | $5M | $641.6K | · | · | |
| Liabilities + Equity | $23M | $8M | $5M | · | · | |
| Shares Outstanding | 9,780,142 | 9,780,142 | 9,780,142 | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| D&A | $-2.3K | $58.0K | · | $167.0K | $160.8K | |
| Stock-based Comp | $-528.9K | $176.5K | · | $160.2K | $856.3K | |
| Other Non-cash | · | $2M | · | · | · | |
| Operating Cash Flow | $-7M | $-3M | · | $-3M | $-4M | |
| CapEx | $136.8K | $658 | · | $0 | $1.2K | |
| Investing Cash Flow | $913.2K | $-650.7K | · | $-250.0K | $-198.0K | |
| Financing Cash Flow | $15M | $7M | · | $3M | $-357.0K | |
| Net Change in Cash | $9M | $4M | · | $75.6K | $-4M | |
| Taxes Paid | $89.4K | $6.6K | · | $0 | $33.4K | |
| Free Cash Flow | · | $-3M | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| ROA | -94.3% | -131.7% | · | · | · | |
| ROE | -108.2% | -221.5% | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.6 | 2.1 | · | · | · | |
| Quick Ratio | 4.5 | 1.5 | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Book Value / Share | $2.08 | $0.47 | · | · | · | |
| Cash Flow / Share | · | $-0.23 | · | · | · | |
| Cash / Share | $1.37 | $0.48 | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Market Cap | $15M | · | · | · | · | |
| P/B | 0.8 | · | · | · | · | |
| P / Tangible Book | 1.1 | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-03-28 | 2025-12-31 | 2024-12-31 |
|---|---|---|---|
| Revenue | · | $537.1K | $894.0K |
| Gross Margin % | · | 72.6% | · |
| Operating Margin % | · | -3005.0% | · |
| Net Income | · | $-16M | $-22M |
| Diluted EPS | · | $-2.70 | $-21.91 |
| Metric | 2026-03-28 | 2025-12-31 | 2024-12-31 |
|---|---|---|---|
| Debt / Equity | · | 1.5 | · |
| Current Ratio | · | 0.5 | · |
| Quick Ratio | · | 0.2 | · |
| Metric | 2026-03-28 | 2025-12-31 | 2024-12-31 |
|---|---|---|---|
| Free Cash Flow | · | $-11M | · |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Lazar David E. ×2 filings | Aug. 7, 2026 | 94.30% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 10 insiders · 2 officers · 4 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Lazar David E. | Chief Executive Officer | Aug. 5, 2026 C | 55,057,500 | 0 | 0 | $0 |
| Guido Baechler | Chief Executive Officer | Feb. 13, 2026 A | 605,058 | 0 | 0 | $0 |
| Heinrich Dreismann | Director | Feb. 13, 2026 A | 64,700 | 0 | 0 | $0 |
| Gregory J Tibbitts | Director | Feb. 13, 2026 A | 55,875 | 0 | 0 | $0 |
| Kevin Michael Donahue | 10% owner | Oct. 17, 2025 P | 685,000 | 1 | 0 | $1,034,350 |
| William Caragol | · | Aug. 11, 2026 A | 367,899 | 0 | 0 | $0 |
| Avraham Ben-Tzvi | · | July 22, 2026 A | 252,000 | 0 | 0 | $0 |
| Peter O'Rourke | · | July 22, 2026 A | · | 0 | 0 | $0 |
| Louis R. Buffalino | · | July 22, 2026 A | · | 0 | 0 | $0 |
| David Natan | · | July 22, 2026 A | 137,141 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
QUCY Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
BUY
Median target
$9.00
+576.7%
2 25.0%
Strong Buy
4 50.0%
Buy
2 25.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-10-03Mean target $9.00 +576.7%
Low$9.00
Mean$9.00
High$9.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026